FindTrial
Sign In

Effects of zinc supplementation in HIV infected children on ART

Zinc supplementation in HIV infected children receiving antiretroviral therapy in North India : an interventional single arm trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096526
Enrollment
65
Registered
2025-10-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B20- Human immunodeficiency virus [HIV]disease

Interventions

Intervention1: Zinc 40mg once daily to all enrolled subjects: zinc 40mg after breakfast once daily for 24weeks to all enrolled subjects Control Intervention1: NIL: NIL

Sponsors

Department of PaediatricsSarojini Naidu Children Hospital Moti Lal Nehru Medical College Prayagraj
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Hiv infected children 18 months to 18 years receiving Antiretroviral Therapy

Exclusion criteria

Exclusion criteria: Patients hospitalised with life threatening conditions -shock, ventilatory support, severe sepsis

Design outcomes

Primary

MeasureTime frame
CD4 counts, Viral loads, Serum zinc levelsTimepoint: CD4 counts at start,12th week and 24th week viral load at start and 24th week Serum Zinc levels at start and 24th week—

Secondary

MeasureTime frame
incidence of opportunistic infections, change in anthropometric indices, comparison of s.zinc levels at beginning and end of study, hospital stay if anyTimepoint: from start till end = 24weeks—

Countries

India

Contacts

Public ContactDr Aditi Singh

Moti Lal Nehru Medical College Prayagraj

anubhashrivastava@rediffmail.com9236804326

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026